Transcatheter aortic valve implantation (TAVI) is a relatively new technique that has been
introduced to treat inoperable and high-risk patients with severe aortic stenosis. From its …

With an increasingly elderly population, the incidence of aortic stenosis (AS) is rising. While
surgical aortic valve replacement remains the gold standard treatment for patients with …

Transcatheter aortic valve implantation (TAVI) was first used in clinical practice in 2002.
Since 2002, there has been a rapid increase in TAVI activity in patients with symptomatic …

Cumulative evidence has demonstrated that transcatheter aortic valve implantation (TAVI)
constitutes an effective treatment option for patients with severe symptomatic aortic stenosis …

The efficacy of transcatheter aortic valve implantation (TAVI) in high surgical risk and
inoperable patients with severe aortic stenosis (AS) is rapidly gaining credibility with an ever …

Abstract Transcatheter Aortic Valve Implantation (TAVI) was initially developed to treat aortic
stenosis in patients with high risk for surgical intervention. With great initial adoption of the …

The development of transcatheter aortic valve implantation (TAVI) by our group has been a
20-year odyssey. In 1993, postmortem studies validated the concept of intravalvular stenting …

Transcatheter aortic valve implantation (TAVI) has become the preferred treatment option for
patients with symptomatic severe aortic stenosis who are inoperable or at high risk for …

During the last 15 years, transcatheter aortic valve implantation (TAVI) has gained wide
acceptance with good reproducible clinical and safety outcomes. Today, TAVI has not only …

Over the past decade, approximately 15,000 patients have been randomised in clinical trials
of transcatheter aortic valve implantation (TAVI), and as many patients will be randomised in …